| Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder A Wysokiński, A Margulska, D Strzelecki, I Kłoszewska Nordic journal of psychiatry 69 (5), 346-353, 2015 | 96 | 2015 |
| Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder A Wysokiński, D Strzelecki, I Kłoszewska Diabetes & Metabolic Syndrome: Clinical Research & Reviews 9 (3), 168-176, 2015 | 93 | 2015 |
| Analysis of vitamin D status in major depression O Józefowicz, J Rabe-Jablonska, A Wozniacka, D Strzelecki Journal of Psychiatric Practice® 20 (5), 329-337, 2014 | 50 | 2014 |
| Supplementation of antipsychotic treatment with sarcosine–GlyT1 inhibitor–causes changes of glutamatergic 1 NMR spectroscopy parameters in the left hippocampus in patients with … D Strzelecki, M Podgórski, O Kałużyńska, O Gawlik-Kotelnicka, ... Neuroscience letters 606, 7-12, 2015 | 28 | 2015 |
| A 10-week memantine treatment in bipolar depression: a case report. Focus on depressive symptomatology, cognitive parameters and quality of life D Strzelecki, A Tabaszewska, Z Barszcz, O Józefowicz, P Kropiwnicki, ... Psychiatry Investigation 10 (4), 421, 2013 | 27 | 2013 |
| Adding sarcosine to antipsychotic treatment in patients with stable schizophrenia changes the concentrations of neuronal and glial metabolites in the left dorsolateral … D Strzelecki, M Podgórski, O Kałużyńska, L Stefańczyk, ... International journal of molecular sciences 16 (10), 24475-24489, 2015 | 25 | 2015 |
| Supplementation of antipsychotic treatment with the amino acid sarcosine influences proton magnetic resonance spectroscopy parameters in left frontal white matter in patients … D Strzelecki, M Podgórski, O Kałużyńska, O Gawlik-Kotelnicka, ... Nutrients 7 (10), 8767-8782, 2015 | 23 | 2015 |
| Pegylated interferon α and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients T Pawelczyk, A Pawelczyk, D Strzelecki, J Rabe-Jablonska General hospital psychiatry 30 (6), 501-508, 2008 | 23 | 2008 |
| Refeeding syndrome as treatment complication of anorexia nervosa A Skowrońska, K Sójta, D Strzelecki Psychiatr Pol 53 (5), 1113-23, 2019 | 22 | 2019 |
| Obstructive sleep apnea as an acceleration trigger of cellular senescence processes through telomere shortening S Turkiewicz, M Ditmer, M Sochal, P Białasiewicz, D Strzelecki, ... International Journal of Molecular Sciences 22 (22), 12536, 2021 | 20 | 2021 |
| Disruption of circadian rhythm genes in obstructive sleep apnea patients—possible mechanisms involved and clinical implication A Gabryelska, S Turkiewicz, FF Karuga, M Sochal, D Strzelecki, ... International Journal of Molecular Sciences 23 (2), 709, 2022 | 18 | 2022 |
| Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state M Kotlicka-Antczak, MS Karbownik, K Stawiski, A Pawełczyk, N Żurner, ... European Psychiatry 58, 72-79, 2019 | 17 | 2019 |
| Two grams of sarcosine in schizophrenia–is it too much? A potential role of glutamate-serotonin interaction D Strzelecki, J Szyburska, J Rabe-Jabłońska Neuropsychiatric Disease and Treatment, 263-266, 2014 | 17 | 2014 |
| Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study) D Strzelecki, M Urban-Kowalczyk, A Wysokiński Psychiatry Research, 447-453, 2018 | 16 | 2018 |
| Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture O Gawlik-Kotelnicka, W Mielicki, J Rabe-Jabłońska, J Lazarek, ... Acta Neuropsychiatrica 28 (1), 38-44, 2016 | 16 | 2016 |
| In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present J Arabska, A Łucka, D Strzelecki, A Wysokiński Neuroscience Letters, 2018 | 14 | 2018 |
| Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study) D Strzelecki, M Urban‐Kowalczyk, A Wysokiński Human Psychopharmacology: Clinical and Experimental 33 (2), e2652, 2018 | 13 | 2018 |
| Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis M Kotlicka-Antczak, A Pawełczyk, MS Karbownik, T Pawełczyk, ... Schizophrenia Research 181, 49-54, 2017 | 13 | 2017 |
| The role of inflammation, hypoxia, and opioid receptor expression in pain modulation in patients suffering from obstructive sleep apnea P Kaczmarski, FF Karuga, B Szmyd, M Sochal, P Białasiewicz, ... International Journal of Molecular Sciences 23 (16), 9080, 2022 | 12 | 2022 |
| Adiposity in depression or depression in adiposity? The role of immune-inflammatory-microbial overlap O Gawlik-Kotelnicka, D Strzelecki Life 11 (2), 117, 2021 | 12 | 2021 |
Adam WysokińskiCentral Clinical Hospital, Medical University of Lodz, Poland在 umed.lodz.pl 的电子邮件经过验证
